Geninus Plunges on First Day of KOSDAQ Listing… Falls 33% Below IPO Price
Summary
Geninus, a precision medicine and genomic diagnostics company, fell sharply on its first day of trading on the KOSDAQ. The stock closed 25.56% below its opening price and 33% below its IPO price. The company spun out of Samsung Seoul Hospital’s Future Medicine Research Institute and was founded in 2018. The article also notes that Geninus drew strong subscription demand ahead of listing, but that enthusiasm did not hold up in early trading.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected